Knight Therapeutics, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. SunRock, Escugen Partner To Develo

As Endo gears up to consummate its $6.7bn merger with Mallinckrodt later this year, the firm has completed the divestment of its International Pharmaceuticals business – primarily operated through Can

Despite missing out on a proposed acquisition priced at about four times its share price at the time of offer, TherapeuticsMD Inc. has found an exit for its shareholders by selling off its women’s h

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. BMS Exits 2015 Gene Therapy Partnership